RWA
AMED

Ropes Wealth Advisors’s Amedisys AMED Stock Holding History

Ropes Wealth Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-717
Closed -$210K – 277
2020
Q4 		$210K Sell
717
-144
-17% -$36.9K 0.03% 228
2020
Q3 		$204K Buy
861
+61
+8% +$13.9K 0.04% 199
2020
Q2 		$159K Hold
800
– – 0.03% 206
2020
Q1 		$147K Hold
800
– – 0.04% 193
2019
Q4 		$134K Hold
800
– – 0.03% 246
2019
Q3 		$105K Buy
+800
New +$104K 0.02% 276

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Ropes Wealth Advisors's AMED Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of Amedisys (AMED) in Q1 2021, closing a stake of 717 shares — an estimated $210K sold.

Ropes Wealth Advisors first reported a position in AMED in Q3 2019 and held it in 6 quarters. The position peaked at $210K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Ropes Wealth Advisors reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Ropes Wealth Advisors sold 717 Amedisys shares in Q1 2021, an estimated $210K.
  • Ropes Wealth Advisors first reported a position in Amedisys in Q3 2019 and held it in 6 quarters.
  • Ropes Wealth Advisors's Amedisys position peaked at $210K in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.